Palisade Strategies, LLC

Palisade Strategies, LLC, a Service-Disabled Veteran-Owned Small Business (SDVOSB) headquartered in Valrico, Florida, delivers pharmacy benefit management and prescription fulfillment services exclusively to the Department of Veterans Affairs across nine regional VISNs as a prime contractor (100% of recent awards). The company holds active SBA certifications for both SDVOSB and veteran-owned small business status through January 2029 and operates as a self-certified small disadvantaged business and HUBZone joint venture participant through its subsidiary Palisade-Heritage Joint Venture II, LLC.

Palisade Strategies' service portfolio centers on first-fill and urgent prescription fulfillment, pharmacy refill services, and emergency prescription dispensing at VA medical centers and community-based outpatient clinics. Concrete recent work includes a $1.77 million indefinite delivery contract with VISN 10 covering Ohio, Michigan, and Indiana for first-fill and urgent prescription fulfillment (with a $389,695.92 delivery order awarded April 1, 2026, extending through March 31, 2029); a $4.6 million IDC with VISN 21 for pharmacy refill services through July 31, 2026; and a $500,000 SDVOSB sole-source IDC with VISN 16 for prescription services across nine Arkansas, Missouri, and Oklahoma locations awarded November 28, 2025. The company also holds blanket purchase agreements with VISNs 15, 21, 22, and 23 ranging from $141,000 to $451,277 in ceiling value for pharmacy benefit management and first-fill services.

Customer concentration remains entirely within the VA system. The top five VISNs account for 74% of awards by count and 83% of combined potential value. VISN 22 leads by dollars ($14.1 million across 18 awards), followed closely by VISN 21 ($13.5 million across 26 awards) and VISN 10 ($6.8 million across 30 awards). VISN 15 ($4.9 million, 16 awards) and VISN 16 ($4.5 million, 11 awards) round out the active set. This concentration reflects Palisade Strategies' exclusive positioning as a pharmacy services vendor within the VA healthcare network.

Five parent vehicle IDCs and BPAs anchored the prime footprint over the source period. The largest is a VISN 21 indefinite delivery contract (36C25019D0078) generating 25 task orders valued at $1.1 million combined; a VISN 22 BPA (36C26221A0021) carried 17 task orders worth $5.1 million. Three additional IDCs with VISN 21 and VISN 20 contributed 12 task orders. All work flows through VA VISN-level ordering against single-award or multiple-award indefinite delivery vehicles and blanket purchase agreements, with task orders issued on a firm fixed-price delivery order or BPA call basis. The source does not identify parent agency-wide GWACs or government-wide vehicles; all work is VISN-specific.

Activity has been relatively stable year over year, with 20 awards in 2022, 18 in 2023, 14 in 2024, and 23 in 2025, averaging roughly 15 awards annually. Ten awards (combined potential value $3.6 million) face ultimate completion dates within the next twenty-four months and therefore represent near-term recompete exposure—largely pharmacy refill and benefit management task orders under VISN 21 and VISN 22 vehicles. The company maintains a combined active portfolio of approximately $31.4 million across its VA contracts, indicating sustained ordering volume and relationship depth across multiple VISNs.

Service Contract Inventory data shows Palisade Strategies' SCI-reportable invoiced revenue reached $981 thousand in FY2023 and declined to $310 thousand in FY2024, representing work above the $150,000 threshold. The company deployed 0.3 FTEs in FY2023 and 0.4 FTEs in FY2024 on those captured contracts. Government-paid hourly rates on SCI-reportable prime contracts ranged from a 10th percentile of $145.60/hr to a median of $798.46/hr and a 90th percentile of $2,539.74/hr, reflecting the mix of pharmacy technician, pharmacist, and program management labor embedded in task orders. The vendor self-performs all work; sub-hours averaged 0% across prime contracts in the SCI dataset. SCI captures only a slice of Palisade Strategies' federal pharmacy services activity; the company's $52.8 million combined potential value across 143 awards demonstrates significantly larger federal footprint than SCI-reported invoicing alone.

Palisade Strategies operates exclusively as a prime contractor with no subcontract work in the source data. The company competes primarily under SDVOSB set-asides and sole-source designations, though approximately 40% of recent awards carry no set-aside designation and are issued on full-and-open or sole-source basis under existing IDC/BPA vehicles. This posture reflects both the company's SDVOSB certification advantage within the VA system and its established relationships with regional VISNs that enable direct ordering against standing agreements without new competition.

Palisade Strategies is a pharmacy benefit, PPE supplier, and consulting company that works closely with government entities and commercial self-funded businesses to improve patient care and reduce costs. The company leverages best in class technology coupled with a solution based entrepreneurial team to identify health and cost related issues and develop and implement custom-based solutions.